Literature DB >> 12435776

Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan.

Ming-Whei Yu1, Hung-Chuen Chang, Pei-Jer Chen, Chun-Jen Liu, Yun-Fan Liaw, Shi-Ming Lin, Shou-Dong Lee, Shee-Chan Lin, Chih-Lin Lin, Chien-Jen Chen.   

Abstract

BACKGROUND: There is a tendency for familial aggregation of hepatocellular carcinoma (HCC). The aims of this study were to assess the degree to which familial aggregation of hepatitis B surface antigen (HBsAg) carriers accounts for familiality of HCC in families of hepatitis B-related HCC patients, and whether HCC shares a familial predisposition with liver cirrhosis among HBsAg carriers.
METHODS: A total of 671 first-degree relatives of HBsAg-positive HCC cases were recruited using abdominal ultrasonography and tests for HBsAg and serum aminotransferases. They were from 165 simplex families defined as having only one HCC case and 72 multiplex families with more than one case. In analyses of family history of HCC and cirrhosis, the data set consisted of 4,471 unrelated asymptomatic HBsAg carriers recruited in a prospective study.
RESULTS: There was no significant difference in the HBsAg-positive rate among relatives between multiplex (55.7%) and simplex (48.1%) families. Sonographic evidence of liver cirrhosis was present in 14.4% of HBsAg-positive relatives from multiplex families but in only 7.8% of HBsAg-positive relatives from simplex families (multiplex versus simplex families: adjusted odds ratio [OR] = 2.29; 95% CI: 1.10-4.77). Among unrelated asymptomatic HBsAg carriers, the adjusted OR of liver cirrhosis associated with a first-degree family history of HCC was 2.80 (95% CI: 1.68-4.66). This association was stronger in HBsAg carriers <50 years. No association was seen between family history of HCC and hepatitis activity based on elevated levels of aminotransferases.
CONCLUSIONS: Familial aggregation of HCC in HBsAg carriers is associated with familial clustering of liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435776     DOI: 10.1093/ije/31.5.1008

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  10 in total

1.  The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.

Authors:  Manal M Hassan; Margret R Spitz; Melanie B Thomas; Steven A Curley; Yehuda Z Patt; Jean-Nicolas Vauthey; Katrina Y Glover; Ahmed Kaseb; Richard D Lozano; Adel S El-Deeb; Nga T Nguyen; Steven H Wei; Wenyaw Chan; James L Abbruzzese; Donghui Li
Journal:  J Hepatol       Date:  2008-10-16       Impact factor: 25.083

2.  A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China.

Authors:  Tao-Tao Liu; Ying Fang; Hui Xiong; Tao-Yang Chen; Zheng-Pin Ni; Jian-Feng Luo; Nai-Qing Zhao; Xi-Zhong Shen
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

3.  Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Jian Yan; Xiao-Long Liu; Gang Xiao; Ning-Lei Li; Yi-Nan Deng; Lu-Zhe Han; Liang-Chun Yin; Li-Juan Ling; Li-Xin Liu
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

4.  Hepatocellular carcinoma in identical twins in Chile: case report.

Authors:  Christian Caglevic; Shirley Silva; Mauricio Mahave; Javiera Torres; Christian Rolfo; Jorge Gallardo; Paula Carrasco
Journal:  Ecancermedicalscience       Date:  2016-12-21

5.  Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma.

Authors:  Shao-Jun Zhou; Yue-Ling Deng; Hui-Fang Liang; Jonathan C Jaoude; Fu-Yao Liu
Journal:  Cell Death Differ       Date:  2017-06-02       Impact factor: 15.828

6.  Demographic and Urbanization Disparities of Liver Transplantation in Taiwan.

Authors:  Pei-Hung Wen; Chin-Li Lu; Carol Strong; Yih-Jyh Lin; Yao-Li Chen; Chung-Yi Li; Chiang-Chin Tsai
Journal:  Int J Environ Res Public Health       Date:  2018-01-23       Impact factor: 3.390

7.  Individual and neighborhood socioeconomic status in the prediction of liver transplantation among patients with liver disease: A population-based cohort study in Taiwan.

Authors:  Chi-Chu Liu; Chin-Li Lu; Hari Basuki Notobroto; Chiang-Chin Tsai; Pei-Hung Wen; Chung-Yi Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

8.  Genotypic Resistance Remains A Concern In Chronic Hepatitis B Patients With High Viral Load After Lamivudine And Adefovir Combination Therapy.

Authors:  Meijin Huang; Jie Zhong; Chunlei Lu; Fenglian Deng; Li Li; Yixi Nong; Liudan Liang; Houji Qin; Yibin Deng
Journal:  Pharmgenomics Pers Med       Date:  2019-10-21

9.  Risk prediction models for hepatocellular carcinoma in different populations.

Authors:  Xiao Ma; Yang Yang; Hong Tu; Jing Gao; Yu-Ting Tan; Jia-Li Zheng; Freddie Bray; Yong-Bing Xiang
Journal:  Chin J Cancer Res       Date:  2016-04       Impact factor: 5.087

10.  Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma.

Authors:  Youde Liu; Xiumei Wang; Jing Xiao; Jing Sun; Yinghua Zhang
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.